STEPHANIE FLORES: Open Payments
NPI 1891259461 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 66 payments from 19 companies in 2025. Trend: 2023 $437 · 2024 $2,086 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $189 |
| ABBVIE INC. | 8 | $158 |
| PFIZER INC. | 7 | $137 |
| Lilly USA, LLC | 8 | $118 |
| Exact Sciences Corporation | 5 | $117 |
| Sumitomo Pharma America, Inc. | 4 | $102 |
| Radius Health, Inc. | 4 | $99 |
| Antares Pharma, Inc. | 3 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
Products named: Cologuard Collection Kit, GEMTESA, Tymlos, AIRSUPRA, VRAYLAR, NURTEC ODT, XYOSTED, UBRELVY.
Industry payments across CO — which companies pay providers there.
